Company profile
Candel Therapeutics, Inc. Insider Trading
CADLEvery SEC Form 4 insider trading filing for Candel Therapeutics, Inc. (CADL) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Biological Products, (No Diagnostic Substances)
- CIK
- 0001841387
- Filings
- 129
- Insiders
- 19
- Last filing
- 2026-09-11
Activity summary
Recent insider activity is bullish. Over the last 30 days, 1 insider purchased shares. Buying was led by Martine Zimmermann.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Candel Therapeutics, Inc. insiders are net sellers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $14.7M.
90 day insight
Over the last 90 days, Candel Therapeutics, Inc. insiders bought $34K across 5 transactions with no open-market sales.
- Most active insider: Paul Peter Tak with 4 transactions totaling $3.4M.
- Largest single sale: $2.5M by Paul Peter Tak on Sep 10, 2026.
- 100% of recent sales were pre-scheduled 10b5-1 trades, typically less informative than open-market activity.
Activity skews bullish: buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Paul Peter Tak | CADL | Sale10b5 | 59,379 | $10.46 | $621K |
| Sep 10, 2026 | Paul Peter Tak | CADL | Option Exercise10b5 | 125,000 | $1.55 | $194K |
| Sep 10, 2026 | Paul Peter Tak | CADL | Sale10b5 | 220,866 | $11.50 | $2.54M |
| Sep 10, 2026 | Paul Peter Tak | CADL | Option Exercise10b5 | 125,000 | — | — |
| Sep 8, 2026 | Martine Zimmermann | CADL | Award | 64,000 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=CADL" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Candel Therapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings: institutional holders report positions within 45 days of quarter end. Joined with insider activity above: see who's loading up institutionally while insiders are trading. Full 13F-HR API →